#foundayo — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #foundayo, aggregated by home.social.
-
LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case
Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…
#NewsBeep #News #Medication #ATTAIN-MAINTAINtrial #CA #Canada #EliLillyandCompany #Foundayo #glp-1 #Health #LLY #NovoNordisk #NVO #oralweightlossmedication #weightlossmaintenance #Zepbound
https://www.newsbeep.com/ca/686827/ -
LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case
Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…
#NewsBeep #News #Medication #ATTAIN-MAINTAINtrial #AU #Australia #EliLillyandCompany #Foundayo #GLP-1 #Health #LLY #NovoNordisk #NVO #oralweightlossmedication #weightlossmaintenance #Zepbound
https://www.newsbeep.com/au/687717/ -
LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case
Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…
#NewsBeep #News #Medication #ATTAIN-MAINTAINtrial #AU #Australia #EliLillyandCompany #Foundayo #GLP-1 #Health #LLY #NovoNordisk #NVO #oralweightlossmedication #weightlossmaintenance #Zepbound
https://www.newsbeep.com/au/687717/ -
https://www.europesays.com/uk/978209/ LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case #ATTAINMAINTAINTrial #EliLillyAndCompany #Foundayo #GLP1 #Health #LLY #Medication #NovoNordisk #NVO #OralWeightLossMedication #UK #UnitedKingdom #WeightLossMaintenance #Zepbound
-
https://www.europesays.com/ie/497670/ LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case #ATTAINMAINTAINTrial #Éire #EliLillyAndCompany #Foundayo #GLP1 #Health #IE #Ireland #LLY #Medication #NovoNordisk #NVO #OralWeightLossMedication #WeightLossMaintenance #Zepbound
-
Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss
Eli Lilly and Co. (NYSE:LLY) on Wednesday released detailed findings from two late-stage obesity studies showing patients were…
#NewsBeep #News #Medication #ATTAIN-MAINTAIN #AU #Australia #EliLilly #Foundayo #Health #maximumtolerateddose #SURMOUNT-MAINTAIN #WeightLoss
https://www.newsbeep.com/au/672116/ -
Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss
Eli Lilly and Co. (NYSE:LLY) on Wednesday released detailed findings from two late-stage obesity studies showing patients were…
#NewsBeep #News #Medication #ATTAIN-MAINTAIN #AU #Australia #EliLilly #Foundayo #Health #maximumtolerateddose #SURMOUNT-MAINTAIN #WeightLoss
https://www.newsbeep.com/au/672116/ -
https://www.europesays.com/ie/485581/ Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss #ATTAINMAINTAIN #Éire #EliLilly #Foundayo #Health #IE #Ireland #MaximumToleratedDose #Medication #SURMOUNTMAINTAIN #WeightLoss
-
https://www.europesays.com/dk/76750/ Novo Nordisk Q1 2026 Earnings: Revenue, Profit Beat; Full-Year Forecast Narrowed | Reuters – News and Statistics #EliLilly #Foundayo #Mounjaro #NovoNordisk #NovoLog #Victoza #Wegovy #WegovyPill #ZeitaLevemir
-
https://www.europesays.com/dk/76609/ Novo sees comeback as weight-loss pill boom revives investor confidence – Firstpost #DenmarkPharma #EliLilly #Foundayo #GLP1Drugs #HealthcareStocks #NovoNordisk #NovoShares #ObesityDrugs #ObesityTreatmentMarket #ozempic #PeptideTherapies #PharmaNews #WegovyPill #WeightLossDrugCompetition #WeightLossPill
-
https://www.europesays.com/dk/75598/ Novo Nordisk Share Price: Obesity Pill Ka Craze Hai, Par Profitability Ki Testing Shuru! #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket
-
https://www.europesays.com/dk/75448/ Novo Nordisk’s Obesity Pill Demand Soars, Profitability Faces Tough Test #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket
-
FuturHealth expands digital health platform to boost convenience for oral GLP-1 drugs
Clinical guidance health platform FuturHealth has expanded its oral GLP-1 receptor agonist options with orforglipron — branded Foundayo…
#UnitedStates #US #USA #america #EliLilly #Entertainment #Foundayo #FuturHealthExpansion #health #OralGLP-1 #sports #unitedstatesofamerica
https://www.europesays.com/2953599/ -
https://www.europesays.com/dk/69223/ Novo Nordisk’s Oral Pill Crushes Lilly’s Foundayo in Prescription Race, but a 50% Stock Rout Tel #Crushes #Foundayo #Lillys #Nordisk’s #novo #NovoNordisk #Oral #pill #prescription #race #stock
-
https://www.europesays.com/dk/63186/ Eli Lilly’s Foundayo And Novo Nordisk’s Wegovy – A Look At Some Key Highlights #EliLillyShares #EliLillyStock #EliLillyStockPrice #Foundayo #NovoNordisk #Wegovy
-
Eli Lilly's Oral Weight-Loss Drug Sees Initial Uptake Amidst Regulatory Scrutiny
Eli Lilly's new oral weight-loss drug Foundayo had 1,400 prescriptions in its first week. The FDA is checking its safety. Find out who is affected.
#Foundayo, #EliLilly, #WeightLossDrug, #FDASafety, #Orforglipron
https://newsletter.tf/eli-lilly-foundayo-drug-fda-safety-checks/
-
Eli Lilly's Foundayo drug received nearly 1,400 prescriptions in its first week, showing strong initial demand. This is a new oral option for weight loss.
#Foundayo, #EliLilly, #WeightLossDrug, #FDASafety, #Orforglipron
https://newsletter.tf/eli-lilly-foundayo-drug-fda-safety-checks/ -
https://www.europesays.com/dk/60388/ FDA Approves Foundayo, a New Oral Weight-Loss Drug Like Ozempic #FDA #FoodAndDrugAdministration #Foundayo #NovoNordisk #ozempic #pill #UnitedStates #WeightLoss
-
https://www.europesays.com/dk/?p=56921 Cost, convenience drive shift to weight-loss pills #EliLilly #Foundayo #GLP1Therapies #InjectableDrugs #NovoNordisk #ObesityMarket #patients #PillBasedWeightLossTreatments #US #Washington #Wegovy
-
FDA grants full approval to Eli Lilly’s once‑daily GLP‑1 obesity pill Foundayo
📰 Original title: FDA Approves Eli Lilly’s GLP-1 Pill
🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅View full AI summary: https://killbait.com/en/fda-grants-full-approval-to-eli-lillys-once-daily-glp-1-obesity-pill-foundayo/?redirpost=292e6cab-5cb7-4569-b53a-e6d70a567101
-
FDA grants full approval to Eli Lilly’s once‑daily GLP‑1 obesity pill Foundayo
📰 Original title: FDA Approves Eli Lilly’s GLP-1 Pill
🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅View full AI summary: https://killbait.com/en/fda-grants-full-approval-to-eli-lillys-once-daily-glp-1-obesity-pill-foundayo/?redirpost=292e6cab-5cb7-4569-b53a-e6d70a567101
-
FDA grants full approval to Eli Lilly’s once‑daily GLP‑1 obesity pill Foundayo
📰 Original title: FDA Approves Eli Lilly’s GLP-1 Pill
🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅View full AI summary: https://killbait.com/en/fda-grants-full-approval-to-eli-lillys-once-daily-glp-1-obesity-pill-foundayo/?redirpost=292e6cab-5cb7-4569-b53a-e6d70a567101
-
FDA grants full approval to Eli Lilly’s once‑daily GLP‑1 obesity pill Foundayo
📰 Original title: FDA Approves Eli Lilly’s GLP-1 Pill
🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅View full AI summary: https://killbait.com/en/fda-grants-full-approval-to-eli-lillys-once-daily-glp-1-obesity-pill-foundayo/?redirpost=292e6cab-5cb7-4569-b53a-e6d70a567101
-
https://www.europesays.com/hu/49364/ Újabb testsúlycsökkentő gyógyszert engedélyeztek az Egyesült Államokban #DavidRicks #egészségügy #ÉlelmiszerésGyógyszerügyiHatóság #EliLilly #fda #Foundayo #GLP1TípusúGyógyszerek #gyógyszeripar #Hungarian #LillyDirectProgram #Magyar #News #NovoNordisk #ÖbölMentiállamok #orforglipron #TestsúlycsökkentőTabletta #Világ #Wegovy #World #WorldNews
-
Update: New Options for Weight Loss
The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like #Zepbound (#tirzepatide), #Wegovy (#semaglutide), #Foundayo (#orforglipron) and #retatrutide.
-
Update: New Options for Weight Loss
The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like #Zepbound (#tirzepatide), #Wegovy (#semaglutide), #Foundayo (#orforglipron) and #retatrutide.
-
Update: New Options for Weight Loss
The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like #Zepbound (#tirzepatide), #Wegovy (#semaglutide), #Foundayo (#orforglipron) and #retatrutide.
-
Update: New Options for Weight Loss
The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like #Zepbound (#tirzepatide), #Wegovy (#semaglutide), #Foundayo (#orforglipron) and #retatrutide.
-
Update: New Options for Weight Loss
The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like #Zepbound (#tirzepatide), #Wegovy (#semaglutide), #Foundayo (#orforglipron) and #retatrutide.
-
https://www.europesays.com/dk/?p=53659 Battle of the Giants: Lilly’s New Weight-Loss Pill vs. Novo Nordisk #EliLilly #FDAApproval #Foundayo #GLP1 #NovoNordisk #ObesityTreatment #orforglipron #PharmaceuticalCompetition #ThyroidTumors #WeightLoss
-
https://www.europesays.com/dk/53576/ Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill #ClinicalTrials #EliLilly #FDA #Foundayo #GLP1Drugs #NovoNordisk #Obesity #WeightLoss